Examples are DIAPH3 in hepatocellular carcinoma cells [288]; FMNL1 in non-small cell lung cancer cells [293], clear cell renal cell carcinoma cells [281] and nasopharyngeal carcinoma cells [277]; FMNL2 in gastric cancer cells [312] and colorectal carcinoma cells [262]; FMNL3 in nasopharyngeal carcinoma cells and tumor xenografts [279]; and FHOD1 in lung carcinoma [294]. Here, FMNL1 is linked to nasopharyngeal carcinoma.